Divi's Laboratories Ltd. logo

Divi's Laboratories Ltd. (DIVISLAB)

Market Closed
12 Jun, 10:00
XNSE XNSE
6,638. 00
-17.5
-0.2629%
1.57T Market Cap
- P/E Ratio
120% Div Yield
162,810 Volume
- Eps
6,655.5
Previous Close
Add Transaction
Day Range
6,622 6,738.5
Year Range
5,636.5 7,071.5
Want to track DIVISLAB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

DIVISLAB closed today lower at ₹6,638, a decrease of -0.2629% from yesterday's close, completing a monthly decrease of -0.7773% or -₹52. Over the past 12 months, DIVISLAB stock gained 3.7512%.
DIVISLAB pays dividends to its shareholders, with the most recent payment made on Aug 16, 2025. The next estimated payment will be in In 2 months on Aug 16, 2026 for a total of ₹30.
The last earnings report, released on May 14, 2026, missed the consensus estimates by -25.33%. On average, the company has fell short of earnings expectations by -6.99%, based on the last three reports.
Divi's Laboratories Ltd. has completed 3 stock splits, with the recent split occurring on Sep 23, 2015.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).

DIVISLAB Chart

People also search for

Sun Pharmaceutical Industries Ltd.
1,807.7
+0.7524%
Tata Motors Ltd.
375.9
-1.3386%
Maruti Suzuki India Limited
13,350
+1.924%
M&M
Mahindra & Mahindra Ltd.
3,042.9
+1.3996%
Bajaj Auto Limited
10,063
-0.5043%

Divi's Laboratories Ltd. (DIVISLAB) FAQ

What is the stock price today?

The current price is ₹6,638.00.

On which exchange is it traded?

Divi's Laboratories Ltd. is listed on XNSE.

What is its stock symbol?

The ticker symbol is DIVISLAB.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 120%.

What is its market cap?

As of today, the market cap is 1.57T.

Has Divi's Laboratories Ltd. ever had a stock split?

Divi's Laboratories Ltd. had 3 splits and the recent split was on Sep 23, 2015.

Divi's Laboratories Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm CEO
XNSE Exchange
Y2076F112 CUSIP
India Country
9,741 Employees
24 Jul 2026 Last Dividend
30 Jul 2009 Last Split
- IPO Date

Overview

Divi's Laboratories Limited is a prominent player in the pharmaceutical industry, specializing in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals. With a strong presence in India, North America, Asia, and Europe, the company has carved a niche for itself on the international stage. Besides its core offerings, Divi's Laboratories extends its expertise to custom synthesis and contract manufacturing services of APIs and intermediates, catering to a diverse client base. Initially established as Divi's Research Center in 1990, the company underwent a rebranding in 1994 to become Divi's Laboratories Limited. Headquartered in Hyderabad, India, it has grown substantially over the years, driven by a commitment to quality and innovation in the pharmaceutical sector.

Products and Services

Divi's Laboratories Limited offers a wide array of products and services catering to the needs of the pharmaceutical, food, dietary supplement, and feed manufacturers industries. These offerings underscore the company's versatility and expertise in the field.

  • Generic Active Pharmaceutical Ingredients (APIs): Divi's specializes in the development and sale of high-quality APIs used in various generic medications. These ingredients are crucial for the production of effective and safe pharmaceutical products.
  • Intermediates: The company manufactures intermediates, which are chemical compounds used in the synthesis of APIs. These intermediates are critical for the pharmaceutical industry, facilitating the production of complex APIs.
  • Nutraceuticals: Recognizing the growing demand for health and wellness products, Divi's Laboratories produces a range of nutraceuticals. These products contribute to health maintenance, act as dietary supplements, and offer therapeutic benefits.
  • Custom Synthesis and Contract Manufacturing Services: Divi's offers tailor-made synthesis services for APIs and intermediates. This service caters to clients requiring specific compounds for their pharmaceutical products, emphasizing the company’s adaptability and capacity for innovation.
  • Carotenoids: The company provides a variety of carotenoids, including beta carotene, astaxanthin, lycopene, and canthaxanthin. These are widely used in the food, dietary supplement, and feed industries for their nutritional and coloring properties.
  • Other Finished Forms: Divi’s Laboratories supplies a range of finished forms like lutein and vitamins. Targeting food, dietary supplement, and feed manufacturers, these products are integral for enhancing nutritional content and market appeal.

Contact Information

Address: Divi Towers
Phone: 91 40 6696 6300